# CORRESP — Nuvectis Pharma, Inc.  (NVCT)  (CIK 0001875558)

> <strong>Nuvectis Pharma, Inc.  (NVCT)  (CIK 0001875558) → SEC staff</strong> · filed 2026-02-18 · ticker NVCT · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-26-017097
- **Form:** CORRESP
- **Filer:** Nuvectis Pharma, Inc.  (NVCT)  (CIK 0001875558)
- **CIK:** 0001875558
- **Ticker:** NVCT
- **Filed:** 2026-02-18
- **SIC industry:** 2834
- **HQ:** Fort Lee, NJ

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1875558/000110465926017097/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1875558&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Nuvectis Pharma, Inc.  (NVCT)  (CIK 0001875558)

- UPLOAD — 2026-02-18 — /comment-letter/0000000000-26-001655

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Nuvectis Pharma, Inc.  (NVCT)  (CIK 0001875558) (CIK 0001875558), filed 2026-02-18, accession 0001104659-26-017097. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001104659-26-017097.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*